156 related articles for article (PubMed ID: 11430545)
41. Relationship of administered dose to blood venom levels in mice following experimental envenomation by Russell's viper (Vipera russelli) venom.
Mg-Mg-Thwin ; Thein-Than ; Hla-Pe U
Toxicon; 1985; 23(1):43-52. PubMed ID: 3922088
[TBL] [Abstract][Full Text] [Related]
42. Characterisation of some pharmacological effects of the venom from Vipera lebetina.
Fatehi-Hassanabad Z; Fatehi M
Toxicon; 2004 Mar; 43(4):385-91. PubMed ID: 15051401
[TBL] [Abstract][Full Text] [Related]
43. An agonist of CXCR4 induces a rapid recovery from the neurotoxic effects of Vipera ammodytes and Vipera aspis venoms.
Stazi M; Megighian A; D'Este G; Negro S; Ivanušec A; Lonati D; Pirazzini M; Križaj I; Montecucco C
J Neurochem; 2024 Apr; 168(4):428-440. PubMed ID: 36912731
[TBL] [Abstract][Full Text] [Related]
44. Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration.
Sorkine P; Setton A; Halpern P; Miller A; Rudick V; Marmor S; Klausner JM; Goldman G
Crit Care Med; 1995 Aug; 23(8):1377-81. PubMed ID: 7634808
[TBL] [Abstract][Full Text] [Related]
45. Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite.
Moura-da-Silva AM; Laing GD; Paine MJ; Dennison JM; Politi V; Crampton JM; Theakston RD
Eur J Immunol; 1996 Sep; 26(9):2000-5. PubMed ID: 8814237
[TBL] [Abstract][Full Text] [Related]
46. Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment.
Czajka U; Wiatrzyk A; Lutyńska A
Przegl Epidemiol; 2013; 67(4):641-6, 729-33. PubMed ID: 24741911
[TBL] [Abstract][Full Text] [Related]
47. Toxicity evolution of Vipera aspis aspis venom: identification and molecular modeling of a novel phospholipase A(2) heterodimer neurotoxin.
Jan V; Maroun RC; Robbe-Vincent A; De Haro L; Choumet V
FEBS Lett; 2002 Sep; 527(1-3):263-8. PubMed ID: 12220671
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals.
Pivko-Levy D; Munchnak I; Rimon A; Balla U; Scolnik D; Hoyte C; Voliovitch Y; Glatstein M
Clin Toxicol (Phila); 2017 Apr; 55(4):235-240. PubMed ID: 28103732
[TBL] [Abstract][Full Text] [Related]
49. Snake bite: pit vipers.
Peterson ME
Clin Tech Small Anim Pract; 2006 Nov; 21(4):174-82. PubMed ID: 17265901
[TBL] [Abstract][Full Text] [Related]
50. Is coagulopathy a common consequence of a Vipera berus bite? A retrospective single centre study.
Dyląg-Trojanowska KE; Hodorowicz-Zaniewska D; Zybaczyńska J; Szczepanik AM
Ann Agric Environ Med; 2018 Dec; 25(4):630-634. PubMed ID: 30586978
[TBL] [Abstract][Full Text] [Related]
51. Dysphonia, an uncommon symptom of systemic neurotoxic envenomation by Vipera aspis bite. Report of two cases.
Beer E; Putorti F
Toxicon; 1998 May; 36(5):697-701. PubMed ID: 9655630
[TBL] [Abstract][Full Text] [Related]
52. Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation.
Lewin M; Samuel S; Merkel J; Bickler P
Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27571102
[TBL] [Abstract][Full Text] [Related]
53. Antagonization of tumor necrosis factor in snake bite. A new approach for an old threat.
Abroug F; Nouira S
Intensive Care Med; 2001 May; 27(5):800-2. PubMed ID: 11430534
[No Abstract] [Full Text] [Related]
54. cDNA cloning, structural, and functional analyses of venom phospholipases A₂ and a Kunitz-type protease inhibitor from steppe viper Vipera ursinii renardi.
Tsai IH; Wang YM; Cheng AC; Starkov V; Osipov A; Nikitin I; Makarova Y; Ziganshin R; Utkin Y
Toxicon; 2011 Feb; 57(2):332-41. PubMed ID: 21185324
[TBL] [Abstract][Full Text] [Related]
55. Viper bites in France: clinical and biological evaluation; kinetics of envenomations.
Audebert F; Sorkine M; Robbe-Vincent A; Bon C
Hum Exp Toxicol; 1994 Oct; 13(10):683-8. PubMed ID: 7826686
[TBL] [Abstract][Full Text] [Related]
56. Some pharmacological studies on the effects of Cerastes vipera (Sahara sand viper) snake venom.
Alzahaby M; Rowan EG; Young LC; al-Zahaby AS; Abu-Sinna G; Harvey AL
Toxicon; 1995 Oct; 33(10):1299-311. PubMed ID: 8599181
[TBL] [Abstract][Full Text] [Related]
57. The establishment and evaluation of a swine model of deinagkistrodon acutus snakebite envenomation.
Lai L; Xie L; Chen Y; Du W; Yang X; Liu W; Shangguan P; Xu J; Lan P
Toxicon; 2024 Apr; 241():107683. PubMed ID: 38460604
[TBL] [Abstract][Full Text] [Related]
58. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
[TBL] [Abstract][Full Text] [Related]
59. Hyperglycemia is a risk factor for high-grade envenomations after European viper bites (Vipera spp.) in children.
Claudet I; Grouteau E; Cordier L; Franchitto N; Bréhin C
Clin Toxicol (Phila); 2016; 54(1):34-9. PubMed ID: 26582080
[TBL] [Abstract][Full Text] [Related]
60. Protective Effect of the Sulfated Agaran Isolated from the Red Seaweed Laurencia aldingensis Against Toxic Effects of the Venom of the Snake, Lachesis muta.
da Silva AC; Ferreira LG; Duarte ME; Fujii MT; Sanchez EF; Noseda MD; Fuly AL
Mar Biotechnol (NY); 2016 Dec; 18(6):619-629. PubMed ID: 27888371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
